AMPH vs CLOV
Amphastar P (AMPH) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AMPH and CLOV stock pages for the full models.
Not investment advice.